Degrome Therapeutics
UEI: PSPLN2KBM7C9
Overview
Awardee Type
Parent
Name
Degrome Therapeutics
Headquarters
Indianapolis, IN
United States
United States
Most Recent Award
Sept. 1, 2024
Calculating
Federal grant recipient
DEGROME THERAPEUTICS, INC.
(UEI PSPLN2KBM7C9)
is headquartered in Indianapolis IN.
The corporation
was founded in October 2023 and
federally registered in
November 2023.
Federal Award Analysis
Degrome Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
DEGROME THERAPEUTICS, INC.
UEI
PSPLN2KBM7C9
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
Oct. 20, 2023
Initial Registration
Nov. 1, 2023
Last Registration
Nov. 13, 2024
Registration Activation
Oct. 11, 2024
Registration Expiration
Oct. 10, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
IN
Country of Incorporation
USA
Reported NAICS
None Reported
Accepts Credit Cards
No